NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
Icahn School of Medicine at Mount Sinai, New York
y 2 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Columbia University Medical Center, New York
Memorial Sloan Kettering, New York

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06234605

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

Research Site, New York

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT07205822

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06625775

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Roswell Park Comprehensive, Buffalo

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT05287945

A Study of ASP3082 in Adults With Advanced Solid Tumors

Roswell Park Cancer Institute, Buffalo
Columbia University - Herbert Irving Comprehensive Cancer Center, New York
Memorial Sloan Kettering Cancer Center, New York
y 1 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT05382559

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Roswell Park Cancer Institute, Buffalo
Icahan School of Medicine at Mount Sinai, New York
University of Rochester Medical Center, Rochester

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06943755

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Montefiore Medical Center-Einstein Campus, The Bronx
Montefiore Medical Center-Weiler Hospital, The Bronx
Montefiore Medical Center - Moses Campus, The Bronx

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT05803382

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

NYOH Albany Cancer Center, Albany
Hematology-Oncology Associates of Central New York, PC, Auburn
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
y 12 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07222800

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Columbia University Irving Medical Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07277413

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, New York
Research Site, Stony Brook

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07007559

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Icahn School of Medicine at Mount Sinai, New York
University of Rochester Medical Center, Rochester

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06989437

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07612176

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

New York Oncology Hematology, Albany
New York Oncology Hematology, Clifton Park
Hematology Oncology Associates of Rockland, Nyack

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07222566

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT05118789

Intratumoral N17350 in Advanced Solid Tumors

Roswell Park Comprehensive Cancer Center, Buffalo

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07339176

A Study of ZEN003694 in People With Squamous Cell Lung Cancer

Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), East White Plains
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
y 1 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT05607108

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

Columbia University Irving Medical Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT06915753

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

New York University (NYU) Langone Medical Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07114601

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Roswell Park Cancer Institute, Buffalo
Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
y 3 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07213804

SLV-154 Treatment of Advanced Cancers

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 12 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06771219

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medical College, New York
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

NYOH Albany Cancer Center, Albany
New York University (NYU) Brooklyn, Brooklyn
Memorial Sloan Kettering Cancer Center, New York
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07174336

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

START New York-Long Island, Lake Success
Memorial Sloan Kettering Cancer Center (MSKCC), New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07262619

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Columbia University, New York
NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

NYU Langone Health Perlmutter Cancer Center, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT07629960

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Memorial Sloan Kettering Cancer Center - Main Campus, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT07450859

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

New York Oncology Hematology, P.C., Albany
New York Oncology Hematology - Clifton Park Cancer Center, Clifton Park
MSK Commack, Commack
y 7 más

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07227415

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

Memorial Sloan Kettering Cancer Center ( Site 0006), New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT06863272

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

Tisch Cancer Institute (TCI), Icahn School of Medicine, New York
Columbia University, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT04977453

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Clinical Study Site, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 sept 2026 · NCT07335497

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Columbia University Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06561685

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Maimonides Cancer Center, Brooklyn
Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
y 3 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06119581

NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies

Montefiore, The Bronx

ReclutandoFase 1

Edades de 19 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT07563829

De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.